• Accueil >
  • Publications >
  • Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers

Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers

15 mai 2016International Journal of Cancer

DOI : 10.1002/ijc.29974

Auteurs

Rana Hatem, Dalila Labiod, Sophie Château-Joubert, Ludmilla de Plater, Rania El Botty, Sophie Vacher, Florian Bonin, Jean-Luc Servely, Véronique Dieras, Ivan Bièche, Elisabetta Marangoni

Membres